# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA646270 | Binding | Compound was evaluated for Inhibition of Adenylate cyclase activity of NG108-15 membranes at the concentration of 10e- 5 moles | 1 | ALA1123280 | assay format | Scientific Literature | ||
2. | ALA646271 | Binding | Compound was evaluated for Inhibition of Adenylate cyclase activity of NG108-15 membranes at the concentration of 10e- 5.4 moles | 1 | ALA1123280 | assay format | Scientific Literature | ||
3. | ALA644604 | Binding | Compound was evaluated for Inhibition of Adenylate cyclase activity of NG108-15 membranes at the concentration of 10e- 5.7 moles | 1 | ALA1123280 | assay format | Scientific Literature | ||
4. | ALA644605 | Binding | Compound was evaluated for Inhibition of Adenylate cyclase activity of NG108-15 membranes at the concentration of 10e- 6 moles | 1 | ALA1123280 | assay format | Scientific Literature | ||
5. | ALA644606 | Binding | Compound was evaluated for Inhibition of Adenylate cyclase activity of NG108-15 membranes at the concentration of 10e- 6.8 moles | 1 | ALA1123280 | assay format | Scientific Literature | ||
6. | ALA644607 | Binding | Compound was evaluated for Inhibition of Adenylate cyclase activity of NG108-15 membranes at the concentration of 10e- 7 moles | 1 | ALA1123280 | assay format | Scientific Literature | ||
7. | ALA644608 | Binding | Compound was evaluated for Inhibition of Adenylate cyclase activity of NG108-15 membranes at the concentration of 10e- 7.2 moles | 1 | ALA1123280 | assay format | Scientific Literature | ||
8. | ALA644609 | Binding | Compound was evaluated for Inhibition of Adenylate cyclase activity of NG108-15 membranes at the concentration of 10e- 7.6 moles | 1 | ALA1123280 | assay format | Scientific Literature | ||
9. | ALA644610 | Binding | Compound was evaluated for Inhibition of Adenylate cyclase activity of NG108-15 membranes at the concentration of 10e- 8 moles | 1 | ALA1123280 | assay format | Scientific Literature | ||
10. | ALA644611 | Binding | Compound was evaluated for Inhibition of Adenylate cyclase activity of NG108-15 membranes at the concentration of 10e- 8.2 moles | 1 | ALA1123280 | assay format | Scientific Literature | ||
11. | ALA644612 | Binding | Compound was evaluated for Inhibition of Adenylate cyclase activity of NG108-15 membranes at the concentration of 10e-6.4 moles | 1 | ALA1123280 | assay format | Scientific Literature | ||
12. | ALA644613 | Binding | Compound was evaluated for Inhibition of Adenylate cyclase activity of NG108-15 membranes at the concentration of 10e-8.6 moles | 1 | ALA1123280 | assay format | Scientific Literature | ||
13. | ALA644614 | Binding | Compound was evaluated for Inhibition of Adenylate cyclase activity of NG108-15 membranes at the concentration of 10e-9 moles | 1 | ALA1123280 | assay format | Scientific Literature | ||
14. | ALA664673 | Binding | Effect of 0 nM compound on [3H]DADL (4.2 nM) binding to lower affinity binding site of opioid receptor using DpLp (50 nM); expressed as % of control | 2 | ALA1124691 | single protein format | Scientific Literature | ||
15. | ALA664674 | Binding | Effect of 10 nM compound on [3H]FOXY (2.8 nM) binding to opioid receptor binding site using [3H]-DADL (4.2 nM); expressed as % of control | 2 | ALA1124691 | single protein format | Scientific Literature | ||
16. | ALA664676 | Binding | Effect of 1000 nM compound on [3H]FOXY (2.8 nM) binding to opioid receptor binding site using [3H]-DADL (4.2 nM); expressed as % of control | 2 | ALA1124691 | single protein format | Scientific Literature | ||
17. | ALA664678 | Binding | Effect of 10000 nM compound on [3H]DADL (4.2 nM) binding to lower affinity binding site of opioid receptor using DpLp (50 nM); expressed as % of control | 2 | ALA1124691 | single protein format | Scientific Literature | ||
18. | ALA665330 | Binding | Effect of 1000 nM compound on [3H]DADL (4.2 nM) binding to higher affinity binding site of opioid receptor using LY-164929 (100 nM); expressed as % of control | 2 | ALA1124691 | single protein format | Scientific Literature | ||
19. | ALA665471 | Binding | Effect of 100 nM compound on [3H]DADL (4.2 nM) binding to lower affinity binding site of opioid receptor using DpLp (50 nM); expressed as % of control | 3 | ALA1124691 | single protein format | Scientific Literature | ||
20. | ALA665472 | Binding | Effect of 10 nM compound on [3H]DADL (4.2 nM) binding to higher affinity binding site of opioid receptor using LY-164929 (100 nM); expressed as % of control | 2 | ALA1124691 | single protein format | Scientific Literature |